FDA Drug Recalls

Recalls / Class II

Class IID-0296-2022

Product

Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64

Brand name
Lidocaine Hydrochloride
Generic name
Lidocaine Hydrochloride
Active ingredient
Lidocaine Hydrochloride
Route
Topical
NDC
63739-997
FDA application
ANDA204494
Affected lot / code info
Lot #: 15594, Exp Date 05/2023

Why it was recalled

Superpotent Drug: Minimally superpotent

Recalling firm

Firm
Teligent Pharma, Inc.
Manufacturer
McKesson Corporation dba SKY Packaging
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
105 Lincoln Avenue, Buena, New Jersey 08310

Distribution

Quantity
7,176 bottles
Distribution pattern
Distributed to a wholesaler in CO who further distributed Nationwide in the USA

Timeline

Recall initiated
2021-11-30
FDA classified
2021-12-28
Posted by FDA
2022-01-05
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0296-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.